Tevogen Inc. (TVGN) Stock: Dividends & Earnings

Company Overview:

Market Cap: $0

Trailing PE: N/A

FWD PE: —

Payout Ratio (TTM): —

52-Week Range: $3.64 - $40.00

4.7 Year TVGN Performance Metrics:

Total Return (with DRIP): -98.7% (-60.10% CAGR)

Total Return (no DRIP): -98.7% (-60.10% CAGR)

Share Price: -98.7% (-60.10% CAGR)

Yield on Cost (with DRIP): —

Total Invested: $10,000

Total Value (with DRIP): $133

Total Return $ (with DRIP): -$9,867

TVGN Total Return

1M 3M 6M YTD 1Y 3Y 5Y 10Y

TVGN Price Chart

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Projected Future Returns & Dividends for TVGN

Based on past 4.7-year performance, here are TVGN growth metrics:

Share price CAGR of -60.1%
Dividend CAGR of +0%

Using TVGN CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	TVGN (DRIP)	TVGN - No DRIP
Current Price	$6.62	$6.62
Start Shares	1,510.57	1,510.57
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	1,510.57	1,510.57
Dividends Payment	$0.00	$0.00
Annual Dividends	$0	$0
Yield on cost	0.00%	0.00%
Share Price	$0.00	$6.62
Total Dividends	$0	$0
Final Value	$1	$10,000

Estimated Future Value + Dividends - TVGN

NOTE: Above numbers are our estimate based on TVGN's Dividend and Price CAGR over past 4.7 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Company Info

Tevogen Inc. (TVGN) had its IPO on , and is traded on NASDAQ stock exchange.

Tevogen Inc. is a clinical-stage specialty immunotherapy company focused on developing off-the-shelf, precision T cell therapies for infectious diseases, cancers, and other serious disorders. The company’s ExacTcell technology platform uses CD8+ cytotoxic T lymphocytes to create genetically unmodified cellular therapies designed for broad patient populations and disease-specific targeting. Tevogen’s current pipeline includes programs aimed at acute viral infections, long-term consequences of viral infections, and selected virus-related and non-viral cancers, reflecting its emphasis on highly targeted immunotherapy. The company also works at the intersection of biotechnology and data science through initiatives that support precision medicine and advanced analytical approaches. Headquartered in Warren, New Jersey, and founded in 2020, Tevogen Inc. operates as a biotech platform company seeking to make personalized cell therapies more accessible across major disease areas.

TVGN website: https://tevogen.com